BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18791188)

  • 1. Carbon dioxide negatively modulates N-methyl-D-aspartate receptors.
    Brosnan RJ; Pham TL
    Br J Anaesth; 2008 Nov; 101(5):673-9. PubMed ID: 18791188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C.
    Hahnenkamp K; Durieux ME; Hahnenkamp A; Schauerte SK; Hoenemann CW; Vegh V; Theilmeier G; Hollmann MW
    Br J Anaesth; 2006 Jan; 96(1):77-87. PubMed ID: 16299047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Oz M; Woods AS; Shippenberg T; Kaminski RM
    Synapse; 2004 May; 52(2):84-8. PubMed ID: 15034914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does anesthetic additivity imply a similar molecular mechanism of anesthetic action at N-methyl-D-aspartate receptors?
    Brosnan RJ; Pham TL
    Anesth Analg; 2011 Mar; 112(3):568-73. PubMed ID: 21233494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Buller AL; Larson HC; Morrisett RA; Monaghan DT
    Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Cruz SL; Mirshahi T; Thomas B; Balster RL; Woodward JJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):334-40. PubMed ID: 9655877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
    Williams K
    Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anesthetic synergy between two n-alkanes.
    Brosnan RJ; Fukushima FB; Pham TL
    Vet Anaesth Analg; 2017 May; 44(3):577-588. PubMed ID: 28583773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of gabapentin on N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Hara K; Sata T
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):122-8. PubMed ID: 17073851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
    J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits.
    Cheffings CM; Colquhoun D
    J Physiol; 2000 Aug; 526 Pt 3():481-91. PubMed ID: 10922001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors.
    Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ
    J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermine and arcaine block and permeate N-methyl-D-aspartate receptor channels.
    Araneda RC; Lan JY; Zheng X; Zukin RS; Bennett MV
    Biophys J; 1999 Jun; 76(6):2899-911. PubMed ID: 10354418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc inhibition of rat NR1/NR2A N-methyl-D-aspartate receptors.
    Erreger K; Traynelis SF
    J Physiol; 2008 Feb; 586(3):763-78. PubMed ID: 18048453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-aspartate and NMDA, but not L-aspartate, block AMPA receptors in rat hippocampal neurons.
    Gong XQ; Frandsen A; Lu WY; Wan Y; Zabek RL; Pickering DS; Bai D
    Br J Pharmacol; 2005 Jun; 145(4):449-59. PubMed ID: 15806114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular proton-modulated pore-blocking effect of the anticonvulsant felbamate on NMDA channels.
    Chang HR; Kuo CC
    Biophys J; 2007 Sep; 93(6):1981-92. PubMed ID: 17513365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.